Kaplan‒Meier survival analysis of TCGA data using GEPIA (http://gepia.cancer-pku.cn/) indicated that low expression of PUS10 predicted a poorer prognosis in RCC patients (Fig. 1A), suggesting that it might act as a tumor suppressor. Here, PUS10 is linked to neoplasm.